The extract of Gordonii and its active component, Gordonosides F, promoted glucose-dependent GLP-1 and insulin release, demonstrating a blood glucose-lowering action during the oral glucose tolerance test (OGTT)
Ongoing national drug shortages, high out-of-pocket costs, and limited insurance coverage have made compounded versions an important alternative for many individuals
Patients who combine GLP-1 medications with regular physical activity tend to have better body composition outcomes meaning more of the weight they lose is fat rather than muscle
The GutGLP-1 Axis Explained The "gutGLP-1 axis" describes the two-way conversation between your microbial community and the hormone-producing cells of your intestine
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 283, R99R106.CrossRefGoogle ScholarPubMed Rizvi, SJ, Pizzagalli, DA, Sproule, BA and Kennedy, SH (2016) Assessing anhedonia in depression: potentials and pitfalls
Oxidative stress markers in intestinal mucosa of Tunisian inflammatory bowel disease patients